Literature DB >> 22854637

Blood pressure control in Italian essential hypertensives treated by general practitioners.

Cristina Giannattasio1, Matteo Cairo, Francesca Cesana, Marta Alloni, Paola Sormani, Giulia Colombo, Guido Grassi, Giuseppe Mancia.   

Abstract

BACKGROUND: Adequate control of blood pressure (BP) is limited worldwide. This has serious consequences for public health because in hypertensive patients, uncontrolled BP is associated with a higher incidence of cardiovascular events, particularly stroke. The aim of this study was to investigate BP control in a cohort of treated patients with diagnosed hypertension, who were under general practitioner care in Italy.
METHODS: Data were collected by 2,643 physicians on 8,572 individual Italian patients. Office BP was measured 5 min after seating each patient and then 3-5 min later. For each patient, data such as medical history of patients, physical examination data, antihypertensive drug usage, and self-BP measurement frequency were obtained.
RESULTS: Male prevalence was 48.4%, and mean age was 64.3 ± 10.5 years. Based on the second measurement, BP control (<140/90 mm Hg) was observed in 33.5% of all patients (34.2% in men and 33.4% in women). BP control was much lower for systolic BP than for diastolic BP (35.9 vs. 61.3%, P < 0.0001); moreover, BP control was much more common in patients who were engaged in self-BP measurement (61.2 vs. 38.8%, P < 0.0001). A stricter BP control recommended by the guidelines of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC) (<130/80 mm Hg) was observed in only 5.5% of diabetic patients.
CONCLUSIONS: In treated Italian hypertensives effective BP control remains uncommon largely due to the failure to appropriately reduce the systolic BP. The stricter values recommended by the ESH/ESC guidelines for diabetic patients are achieved only by a small fraction of hypertensive diabetic population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854637     DOI: 10.1038/ajh.2012.108

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.

Authors:  Gino Seravalle; Nevrez Koylan; Istemi Nalbantgil; Nail Caglar; Fosca Quarti-Trevano; Wim Makel; Guido Grassi; Francesco Fici
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-22

2.  Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.

Authors:  F Fici; G Seravalle; N Koylan; I Nalbantgil; N Cagla; Y Korkut; F Quarti-Trevano; W Makel; G Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-11

Review 3.  Apparent and true resistant hypertension: definition, prevalence and outcomes.

Authors:  E Judd; D A Calhoun
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 4.  Lercanidipine in the Management of Hypertension: An Update.

Authors:  Guido Grassi; Nicolàs R Robles; Gino Seravalle; Francesco Fici
Journal:  J Pharmacol Pharmacother       Date:  2017 Oct-Dec

Review 5.  Endovascular Baroreflex Amplification for Resistant Hypertension.

Authors:  Monique E A M van Kleef; Mark C Bates; Wilko Spiering
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

6.  Time spent at blood pressure target and the risk of death and cardiovascular diseases.

Authors:  Sheng-Chia Chung; Mar Pujades-Rodriguez; Bram Duyx; Spiros C Denaxas; Laura Pasea; Aroon Hingorani; Adam Timmis; Bryan Williams; Harry Hemingway
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.